GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer

Zheqiong Yang, Min Peng, Liang Cheng, Kimya Jones, Nita Jane Maihle, Nahid F Mivechi, Lan Ko

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Human breast cancer precursor cells remain to be elucidated. Using breast cancer gene product GT198 (PSMC3IP; alias TBPIP or Hop2) as a unique marker, we revealed the cellular identities of GT198 mutant cells in human breast tumor stroma. GT198 is a steroid hormone receptor coactivator and a crucial factor in DNA repair. Germline mutations in GT198 are present in breast and ovarian cancer families. Somatic mutations in GT198 are present in ovarian tumor stromal cells. Herein, we show that human breast tumor stromal cells carry GT198 somatic mutations and express cytoplasmic GT198 protein. GT198 + stromal cells share vascular smooth muscle cell origin, including myoepithelial cells, adipocytes, capillary pericytes, and stromal fibroblasts. Frequent GT198 mutations are associated with GT198 + tumor stroma but not with GT198 - tumor cells. GT198 + progenitor cells are mostly capillary pericytes. When tested in cultured cells, mutant GT198 induces vascular endothelial growth factor promoter, and potentially promotes angiogenesis and adipogenesis. Our results suggest that multiple lineages of breast tumor stromal cells are mutated in GT198. These findings imply the presence of mutant progenitors, whereas their descendants, carrying the same GT198 mutations, are collectively responsible for forming breast tumor microenvironment. GT198 expression is, therefore, a specific marker of mutant breast tumor stroma and has the potential to facilitate diagnosis and targeted treatment of human breast cancer.

Original languageEnglish (US)
Pages (from-to)1340-1350
Number of pages11
JournalAmerican Journal of Pathology
Volume186
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Breast Neoplasms
Stromal Cells
Neoplasms
Pericytes
Mutation
Adipogenesis
Tumor Microenvironment
Germ-Line Mutation
Steroid Receptors
Neoplasm Genes
Vascular Smooth Muscle
Adipocytes
DNA Repair
Ovarian Neoplasms
Vascular Endothelial Growth Factor A
Smooth Muscle Myocytes
Cultured Cells
Stem Cells
Fibroblasts
Hormones

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer. / Yang, Zheqiong; Peng, Min; Cheng, Liang; Jones, Kimya; Maihle, Nita Jane; Mivechi, Nahid F; Ko, Lan.

In: American Journal of Pathology, Vol. 186, No. 5, 01.05.2016, p. 1340-1350.

Research output: Contribution to journalArticle

Yang, Zheqiong ; Peng, Min ; Cheng, Liang ; Jones, Kimya ; Maihle, Nita Jane ; Mivechi, Nahid F ; Ko, Lan. / GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer. In: American Journal of Pathology. 2016 ; Vol. 186, No. 5. pp. 1340-1350.
@article{b84f9dc803b642e584c8363c2bba24dc,
title = "GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer",
abstract = "Human breast cancer precursor cells remain to be elucidated. Using breast cancer gene product GT198 (PSMC3IP; alias TBPIP or Hop2) as a unique marker, we revealed the cellular identities of GT198 mutant cells in human breast tumor stroma. GT198 is a steroid hormone receptor coactivator and a crucial factor in DNA repair. Germline mutations in GT198 are present in breast and ovarian cancer families. Somatic mutations in GT198 are present in ovarian tumor stromal cells. Herein, we show that human breast tumor stromal cells carry GT198 somatic mutations and express cytoplasmic GT198 protein. GT198 + stromal cells share vascular smooth muscle cell origin, including myoepithelial cells, adipocytes, capillary pericytes, and stromal fibroblasts. Frequent GT198 mutations are associated with GT198 + tumor stroma but not with GT198 - tumor cells. GT198 + progenitor cells are mostly capillary pericytes. When tested in cultured cells, mutant GT198 induces vascular endothelial growth factor promoter, and potentially promotes angiogenesis and adipogenesis. Our results suggest that multiple lineages of breast tumor stromal cells are mutated in GT198. These findings imply the presence of mutant progenitors, whereas their descendants, carrying the same GT198 mutations, are collectively responsible for forming breast tumor microenvironment. GT198 expression is, therefore, a specific marker of mutant breast tumor stroma and has the potential to facilitate diagnosis and targeted treatment of human breast cancer.",
author = "Zheqiong Yang and Min Peng and Liang Cheng and Kimya Jones and Maihle, {Nita Jane} and Mivechi, {Nahid F} and Lan Ko",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ajpath.2016.01.006",
language = "English (US)",
volume = "186",
pages = "1340--1350",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer

AU - Yang, Zheqiong

AU - Peng, Min

AU - Cheng, Liang

AU - Jones, Kimya

AU - Maihle, Nita Jane

AU - Mivechi, Nahid F

AU - Ko, Lan

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Human breast cancer precursor cells remain to be elucidated. Using breast cancer gene product GT198 (PSMC3IP; alias TBPIP or Hop2) as a unique marker, we revealed the cellular identities of GT198 mutant cells in human breast tumor stroma. GT198 is a steroid hormone receptor coactivator and a crucial factor in DNA repair. Germline mutations in GT198 are present in breast and ovarian cancer families. Somatic mutations in GT198 are present in ovarian tumor stromal cells. Herein, we show that human breast tumor stromal cells carry GT198 somatic mutations and express cytoplasmic GT198 protein. GT198 + stromal cells share vascular smooth muscle cell origin, including myoepithelial cells, adipocytes, capillary pericytes, and stromal fibroblasts. Frequent GT198 mutations are associated with GT198 + tumor stroma but not with GT198 - tumor cells. GT198 + progenitor cells are mostly capillary pericytes. When tested in cultured cells, mutant GT198 induces vascular endothelial growth factor promoter, and potentially promotes angiogenesis and adipogenesis. Our results suggest that multiple lineages of breast tumor stromal cells are mutated in GT198. These findings imply the presence of mutant progenitors, whereas their descendants, carrying the same GT198 mutations, are collectively responsible for forming breast tumor microenvironment. GT198 expression is, therefore, a specific marker of mutant breast tumor stroma and has the potential to facilitate diagnosis and targeted treatment of human breast cancer.

AB - Human breast cancer precursor cells remain to be elucidated. Using breast cancer gene product GT198 (PSMC3IP; alias TBPIP or Hop2) as a unique marker, we revealed the cellular identities of GT198 mutant cells in human breast tumor stroma. GT198 is a steroid hormone receptor coactivator and a crucial factor in DNA repair. Germline mutations in GT198 are present in breast and ovarian cancer families. Somatic mutations in GT198 are present in ovarian tumor stromal cells. Herein, we show that human breast tumor stromal cells carry GT198 somatic mutations and express cytoplasmic GT198 protein. GT198 + stromal cells share vascular smooth muscle cell origin, including myoepithelial cells, adipocytes, capillary pericytes, and stromal fibroblasts. Frequent GT198 mutations are associated with GT198 + tumor stroma but not with GT198 - tumor cells. GT198 + progenitor cells are mostly capillary pericytes. When tested in cultured cells, mutant GT198 induces vascular endothelial growth factor promoter, and potentially promotes angiogenesis and adipogenesis. Our results suggest that multiple lineages of breast tumor stromal cells are mutated in GT198. These findings imply the presence of mutant progenitors, whereas their descendants, carrying the same GT198 mutations, are collectively responsible for forming breast tumor microenvironment. GT198 expression is, therefore, a specific marker of mutant breast tumor stroma and has the potential to facilitate diagnosis and targeted treatment of human breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=84961231313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961231313&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2016.01.006

DO - 10.1016/j.ajpath.2016.01.006

M3 - Article

VL - 186

SP - 1340

EP - 1350

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -